The annual number of new drug approvals globally to treat neglected diseases has nearly doubled in recent years, with HIV/AIDS and malaria drugs accounting for 60 percent of the most recent approvals, according to research by The Tufts Center for the Study of Drug Development.
http://www.drugs.com/news/neglected-approvals-up-47113.html?
http://www.drugs.com/news/neglected-approvals-up-47113.html?
No comments:
Post a Comment